IVI RMA North America Rebranded as Everleap Fertility
The fertility provider has unified its clinics under a new name and published fresh data on infertility in the U.S.
Updated on Oct. 13, 2026 in Pregnancy
Live Poll
Is access to fertility treatments becoming better for the average person in the U.S.?
IVI RMA North America has rebranded as Everleap Fertility to consolidate its operations under a single banner. Alongside the announcement, the company released findings from its inaugural Fertility Barometer survey on the state of reproductive health.
Why it matters
The rebrand aims to unify regional practices under one brand to better reflect current advancements in fertility science. It also highlights the company's significant national footprint as it moves to integrate new technologies into its patient care model.
Everleap Fertility operates 65 clinics and 26 IVF laboratories across the U.S. with over 200 medical professionals. Surveys indicate that 21% of U.S. women have experienced infertility, while 63% of those who received IVF successfully had a baby.
The players
Everleap Fertility
This Basking Ridge, New Jersey-based fertility provider is a subsidiary of the Spain-based IVI Institute.
IVI Institute
This parent organization oversees a global network of reproductive medicine services.
Conceivable Life Sciences
This technology company develops automation solutions for embryology and assisted reproductive technology laboratories.
The details
The provider currently utilizes a network of nine practices equipped with a proprietary electronic medical records platform that includes an AI-powered assistant. The organization plans to implement a fully automated embryology lab from Conceivable Life Sciences in 2027.
Timeline
Everleap Fertility announced its rebrand and survey results on October 13, 2026.
The organization plans to launch its first fully automated embryology lab in 2027.
Culture Shift
This rebrand reflects a broader industry move toward consolidating regional specialized clinics into national networks to scale advanced fertility services. It marks a shift in how reproductive health providers utilize proprietary AI technology to standardize patient outcomes.
Patients currently receiving care at clinics under the former IVI RMA brand can expect service continuity under the new name. The integration of an AI-powered medical record platform may streamline communication and administrative processes for those navigating fertility treatments.
The takeaway
Understanding the prevalence of infertility helps individuals better advocate for their own reproductive timelines and health needs. Early consultation with specialists is a common step for many, as statistics show the vast majority of women experiencing issues seek medical guidance.
What happens next
Everleap Fertility intends to introduce a fully automated embryology laboratory in the United States in 2027.
Further reading
Learn more about modern family planning trends in our Pregnancy section.
Live Poll
Is access to fertility treatments becoming better for the average person in the U.S.?
